Table 1. Results of a genome-wide association study for Japanese patients with SLE.

rsIDa	Chr	Position (bp)	Cytoband	Gene	Alleleb	No. subjects		Allele 1 freq.		OR (95%CI)	P
					1/2	Case	Control	Case	Control
rs10168266	2	191,644,049	2q32	STAT4	T/C	891	3,384	0.37	0.27	1.59 (1.42–1.78)	2.7×10−16
rs9501626	6	32,508,322	6p21	HLA region	A/C	891	3,381	0.20	0.12	1.86 (1.62–2.13)	1.0×10−18
rs2230926	6	138,237,759	6q23	TNFAIP3	G/T	891	3,377	0.11	0.069	1.75 (1.47–2.08)	1.9×10−10
rs6964720	7	75,018,280	7q11	HIP1	G/A	891	3,384	0.25	0.19	1.43 (1.27–1.63)	1.3×10−8
rs2254546	8	11,381,089	8p23	BLK	G/A	891	3,384	0.78	0.72	1.42 (1.61–1.25)	4.1×10−8
rs6590330	11	127,816,269	11q24	ETS1	A/G	891	3,368	0.48	0.39	1.44 (1.30–1.60)	1.3×10−11

^aSNPs that satisfied the threshold of P<5.0×10⁻⁸ were indicated.

^bBased on forward strand of NCBI Build 36.3.

SLE, systemic lupus erythematosus; OR, odds ratio.